Correlation Between Blueprint Medicines and Black Diamond
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Black Diamond Therapeutics, you can compare the effects of market volatilities on Blueprint Medicines and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Black Diamond.
Diversification Opportunities for Blueprint Medicines and Black Diamond
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Blueprint and Black is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Black Diamond go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Black Diamond
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.71 times more return on investment than Black Diamond. However, Blueprint Medicines Corp is 1.4 times less risky than Black Diamond. It trades about 0.2 of its potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 8,277 in Blueprint Medicines Corp on August 28, 2024 and sell it today you would earn a total of 1,110 from holding Blueprint Medicines Corp or generate 13.41% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Black Diamond Therapeutics
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Black Diamond Therap |
Blueprint Medicines and Black Diamond Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Black Diamond
The main advantage of trading using opposite Blueprint Medicines and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Correlations Find global opportunities by holding instruments from different markets |